PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2020

Jun 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2020-06-02

Reporting Person: BRYCE RICHARD PAUL (SEE REMARKS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-02	COMMON STOCK	S	89	$10.66	Disposed	77743	Direct

Footnotes

F1: The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.